Study Group: Dasatinib (Sprycel) Prescribers for Chronic Myeloid Leukemia (CML)
Council Members in this Study Group: 47
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
Jeffrey BubisPartner, Hematologist and Medical Oncologist
INTEGRATED COMMUNITY ONCOLOGY NETWORK, LLC
Jeffrey A. Bubis, DO, FACOI, FACP, is a Partner, Hematologist and Medical Oncologist at Cancer Specialists of North Florida (a division of Integrated Community Oncology Network), the largest private oncology practice in northeast Florida. The group provides...
- William Matsui
Associate Professor
Johns Hopkins University - CCWilliam Matsui, MD, is an Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center and the Johns Hopkins School of Medicine in Maryland, since July 2008. Dr. Matsui specializes in clinical and laboratory examination of hematological...
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Physician - Director
- Physician - Division Head
- Partner
- Medical Director
- Director
- Owner
Related Study Groups
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.